Interventional Cardiology

PPIs significantly reduce gastrointestinal bleeding risk in AMI patients on DAPT without increasing cardiovascular events. Read more on clinical implications.

First-in-human helical-fixation leadless pacemaker implantation in the left atrium offers a novel solution for congenital heart disease patients.

A decade-long study confirms excellent survival and low reoperation rates for mitral valve repair at high-volume centres.

Women had similar three-year outcomes with FFR-guided PCI and CABG, whereas men had better outcomes with CABG in FAME 3.

ACURATE neo2 TAVI shows strong 30-day outcomes in severe bicuspid aortic stenosis, with high device success and safety.

Coronary events post-TAVR are uncommon but serious. Patients undergoing PCI have better outcomes, especially with balloon-expandable valves.

The Myval THV series is non-inferior to SAPIEN and Evolut THV series at 30 days, offering a promising TAVI alternative.

Polymer-free stents match biodegradable-polymer stents in PCI outcomes but pose a higher early thrombosis risk, requiring careful clinical consideration.